Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-022704

CHIEF SCIENTIFIC OFFICER sold 12,000 shares at an average $22.49 ($269,841)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lyssikatos Joseph P · CHIEF SCIENTIFIC OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-29 Sale : show line 1 in the form 10b5-1 −11,950 $22.48 $268,687 1,077,986 I
2024-08-29 Sale : show line 2 in the form 10b5-1 −50 $23.08 $1,154 1,077,936 I
Open-market sales · 12,000 sh · avg $22.49 · $269,841
Loading xslF345X05/form4-09032024_090954.xml…